Bosh sahifaLAURUSLABS • NSE
add
Laurus Labs Ltd
Yopilish kursi
1 020,20 ₹
Kunlik diapazon
1 007,80 ₹ - 1 026,90 ₹
Yillik diapazon
501,15 ₹ - 1 040,20 ₹
Bozor kapitalizatsiyasi
548,89 mlrd INR
Oʻrtacha hajm
2,11 mln
Narx/foyda
80,34
Dividend daromadliligi
0,16%
Asosiy maydon
NSE
Yangiliklarda
Trade Brains
9 soat oldin
Pharma stock in focus after CITI maintains ‘Sell’ rating for downside of 42%
1,63%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 16,53 mlrd | 35,12% |
Joriy xarajat | 7,07 mlrd | 16,98% |
Sof foyda | 1,95 mlrd | 882,71% |
Sof foyda marjasi | 11,79 | 627,78% |
Har bir ulushga tushum | 3,61 | 875,68% |
EBITDA | 4,01 mlrd | 126,03% |
Amaldagi soliq stavkasi | 28,09% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 633,80 mln | 41,10% |
Jami aktivlari | 94,15 mlrd | 7,86% |
Jami passivlari | 44,82 mlrd | -2,26% |
Umumiy kapital | 49,34 mlrd | — |
Tarqatilgan aksiyalar | 540,08 mln | — |
Narxi/balansdagi bahosi | 11,47 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 9,74% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,95 mlrd | 882,71% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Tashkil etilgan
2005
Sayt
Xodimlar soni
6 167
